These observations suggest an overall modulation of the CLR profile on tumor-infiltrating cDC2s, mostly driven by levels of Dectin-1, DC-SIGN and CD206 (Figure 1C; Supplementary Figure 3B; right panels). Here, MRC1 is linked to neoplasm.